Flavio Rocha, Hedinger Chair of Surgical Oncology and Physician-in-Chief at OHSU Knight Cancer Institute, shared on LinkedIn:
“Kudos to the OHSU Knight Cancer Institute, OHSU Sarcoma team on completing this novel clinical trial of preoperative eribulin and for RP liposarcoma Give Cancer Hell.”
Title: Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B study
Authors: Lara E. Davis, Limin Zhu, Skye C. Mayo, Emile Latour, Byung Park, Wei Huang, Brendan Moloney, Jessica L. Davis, Kristina Wakeman, Brett Sheppard, Kevin G. Billingsley, John Vetto, Cristian D. Valenzuela, Robert L. Eil, Flavio Rocha, Arthur Hung, Christopher W. Ryan.
Read The Full Article
Other articles about Sarcoma on OncoDaily